On October 9th, 2024, the Hataphar High-Tech Pharmaceutical Factory of Ha Tay Pharmacy in Hoa Lac officially received the GMP certification for pharmaceutical manufacturing practices. The certification ceremony was held solemnly at the 5th-floor auditorium of the factory, with the participation of numerous representatives from health departments, members of the Board of Directors, the Executive Board, the Supervisory Board of Ha Tay Pharmaceutical Joint Stock Company and ASKA Pharmaceutical Company of Japan, as well as esteemed delegates and guests from both domestic and foreign countries.
Attending the ceremony on behalf of the Vietnamese government agencies were:
- Dr. Nguyen Manh Cuong – Chief Inspector of the Ministry of Health
- Dr. Ta Manh Hung – Deputy Director of the Drug Administration Department, Ministry of Health
- Pharmacist Vu Duc Canh – Deputy Head of the Quality Management Department, Drug Administration Department, Ministry of Health
- Dr. Nguyen Van Ha – Deputy Director of the Central Institute for Drug Control
- Mr. Nguyen Dac Trung – Deputy Head of Hoa Lac High-Tech Zone
- Pharmacist To Hoai Nam – Head of Pharmaceutical Affairs Department, Hanoi Department of Health
- Pharmacist Nguyen Thi Hong Ha – Director of Hanoi Center for Drug and Cosmetics Testing.
Representing the Ministry of Health Inspection Delegation – Republic of Yemen:
- Ms. Al-Antari, Abeer Hussein Abdullah
- Mr. Al-Antari, Mohammed Hussein Abdulla
- Mr. Ahmed, AbdulHabeb Abdo Taher
Representing ASKA Company – Japan:
- Mr. Takashi Yamaguchi, Chairman of the Board of Directors and his wife
- Mr. Atsushi Maruo, Vice President
- Mr. Sohta Yamaguchi, General Director
and other members of the Company’s Leadership Board
Representing Ha Tay Pharmaceutical Joint Stock Company:
- Mr. Le Van Lo – Chairman of the Board of Directors
- Mr. Le Anh Trung – Vice Chairman of the Board of Directors
- Mr. Le Xuan Thang – General Director
and members of the Board of Directors, the Executive Board, and the Supervisory Board of the Company.
The Hataphar High-Tech Pharmaceutical Plant was commenced in January 2022 with a total initial investment of over VND 820 billion for the first phase, spanning an area of over 45,000 m² in Hoa Lac High-Tech Park, Hanoi. In July 2024, the Hataphar CNC plant completed phase 1 with full construction items and achieved GMP standards; ready for a journey to conquer new heights. “The GMP certification ceremony for the Hataphar High-Tech Pharmaceutical Plant” is a significant milestone, affirming the plant’s remarkable development in applying international standards to pharmaceutical production.
Here are a collection of images captured at the official ceremony where the CNC Hataphar factory was awarded the GMP certification:
